CLAUDIA BORGES: Open Payments
NPI 1710690730 · FALL RIVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$284 in 15 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $207 · 2025 $284
Food & beverage: $284
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Novo Nordisk Inc | 3 | $47 |
| Lilly USA, LLC | 2 | $42 |
| ABBVIE INC. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
Products named: REXULTI, AIRSUPRA, MOUNJARO, Ozempic, QULIPTA, OFEV, Kerendia, GEMTESA.
Industry payments across MA — which companies pay providers there.
